Xometry (NASDAQ:XMTR – Get Free Report) announced its earnings results on Tuesday. The company reported $0.28 EPS for the quarter, topping the consensus estimate of $0.19 by $0.09, FiscalAI reports. The firm had revenue of $252.44 million for the quarter, compared to analysts’ expectations of $235.54 million. Xometry had a positive return on equity of 0.20% and a negative net margin of 1.97%. The firm’s quarterly revenue was up 39.5% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.11 earnings per share.
Here are the key takeaways from Xometry’s conference call:
- Record Q3 performance: Revenue rose 40% year over year to $252 million, marketplace revenue grew 43%, and Xometry reported its first quarter of GAAP profitability with $1.9 million in net income.
- Operating leverage improved materially: Marketplace gross margin reached a record 36.0%, adjusted EBITDA increased to $21.4 million with an 8.5% margin, and advertising spend fell to 3.0% of marketplace revenue.
- Enterprise expansion and buyer growth remained strong, with active buyers up 20% to 93,812, accounts spending at least $50,000 up 26%, and revenue from the largest customers increasing more than 40%. Management also highlighted continued wallet-share gains and expects more customers to surpass $10 million in annual spend.
- Management raised its 2026 outlook to approximately 37% revenue growth and $68 million-$68.5 million of adjusted EBITDA. The Siemens partnership is expected to launch a Designcenter beta in Q1 2027 and contribute positively to 2027 results, although the financial impact has not yet been quantified.
Xometry Price Performance
NASDAQ XMTR opened at $113.52 on Thursday. The stock has a market capitalization of $5.88 billion, a P/E ratio of -333.87 and a beta of 1.33. Xometry has a 1 year low of $35.86 and a 1 year high of $117.50. The business’s fifty day moving average is $97.42 and its two-hundred day moving average is $76.71. The company has a debt-to-equity ratio of 0.41, a quick ratio of 3.20 and a current ratio of 3.21.
Insider Buying and Selling
Wall Street Analysts Forecast Growth
XMTR has been the subject of a number of research reports. UBS Group increased their price target on Xometry from $95.00 to $108.00 and gave the company a “neutral” rating in a research note on Wednesday. Royal Bank Of Canada upped their price objective on Xometry from $100.00 to $117.00 and gave the company a “sector perform” rating in a report on Wednesday. Rosenblatt Securities raised their target price on Xometry from $120.00 to $130.00 and gave the company a “buy” rating in a research note on Wednesday. Wedbush raised their target price on Xometry from $126.00 to $140.00 and gave the company an “outperform” rating in a research note on Wednesday. Finally, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Xometry in a report on Wednesday, August 26th. Eight research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $123.64.
Get Our Latest Stock Analysis on Xometry
Key Xometry News
Here are the key news stories impacting Xometry this week:
- Positive Sentiment: Q3 results beat expectations. Revenue rose 40% year over year to a record $252 million, while marketplace revenue grew 43%. Reported EPS of $0.28 topped the $0.19 consensus. The earnings coverage also highlighted 20% growth in active buyers, to 93,812. Xometry Q3 results Q3 investor takeaways
- Positive Sentiment: Several analysts raised targets, signaling continued optimism. JPMorgan lifted its target to $140 and kept an overweight rating; Citizens JMP raised its target to $135 and maintained market outperform; Citigroup raised its target to $132 and assigned a buy rating; and Rosenblatt raised its target to $130 with a buy rating. Citigroup rating JPMorgan rating Citizens JMP rating
- Neutral Sentiment: Not all target revisions imply meaningful upside. UBS raised its target to $108 but kept a neutral rating, placing its estimate below the quoted share price. RBC’s new $117 target and Cantor Fitzgerald’s $114 target indicate comparatively modest upside. UBS target revision RBC target revision
- Negative Sentiment: Profitability remains a watchpoint. Despite the EPS beat, the supplied results show a negative net margin, leaving investors to assess whether rapid growth can translate into sustained profits.
Xometry Company Profile
Xometry, Inc (NASDAQ:XMTR) operates a technology-driven marketplace that connects businesses seeking custom parts with a network of manufacturing suppliers. Its platform uses automated pricing, manufacturability analysis and digital workflows to help customers source parts and manage production more efficiently.
The company supports a range of manufacturing processes, including CNC machining, 3D printing, sheet metal fabrication, injection molding, urethane casting and other specialized production services.
Recommended Stories
- Five stocks we like better than Xometry
- Why ExxonMobil and Chevron Reminded Investors to Keep it Simple
- Amazon Has Erased Its Earnings Sell-Off, But Is the Biggest Opportunity Still Ahead?
- onsemi’s AI Sales Surge 175%: Is a Stock Recovery Next?
- Energy Transfer’s Earnings Miss May Be Hiding Its Strongest Advantage
Receive News & Ratings for Xometry Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xometry and related companies with MarketBeat.com's FREE daily email newsletter.
